WHO may delay emergency use approval for China's Sinovac vaccine

2021-05-27 04:24:17

According to The Wall Street Journal, WHO may delay emergency use approval for China's Sinovac vaccine.

The World Health Organization (WHO) is asking China's Sinovac Biotech Ltd (SVA: NASDAQ GS) to provide more data on the manufacturing process and the safety of the COVID-19 vaccine CoronaVac.

One senior WHO official now expects a decision to be delayed into June.

Source: https://www.wsj.com/articles/who-seeks-more-data-on-second-chinese-covid-19-vaccine-up-for-approval-11622019526

WHO Chinese Vaccine Sinovac

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Tencent Holdings repurchased 3.93 million shares for HK$1.5 billion on January 7
                            2025-01-07

                                    Ireland recorded a 12.8 billion euro fiscal surplus last year due to the "Apple tax" ruling
                            2025-01-07

                                    Ministry of Industry and Information Technology: Promoting technical verification of 10G optical network and artificial intelligence integration
                            2025-01-07

                                    Tencent's major shareholder Prosus reduced its stake in Tencent Holdings from 24.01% to 23.99% on January 6.
                            2025-01-07

                                    U.S. chip stocks rose before the market opened, with Nvidia up 0.6%
                            2025-01-07